Esentra 120 mg Injection
329,10$
199,45$
Esentra 120 mg Injection, featuring the active ingredient denosumab, is a specialized monoclonal antibody treatment designed for adults facing advanced cancer with bone metastasis. This innovative medication plays a crucial role in mitigating severe complications such as fractures, spinal cord pressure, and the need for radiation therapy or surgical interventions. Additionally, Esentra is indicated for the management of giant cell tumors of the bone in adults who are not candidates for surgical options, particularly those whose skeletal growth has ceased. By targeting specific pathways that lead to bone degradation, Esentra helps maintain bone health and strength during cancer treatment. Patients should be aware of potential side effects, including increased risk of infections or atypical fractures, making regular monitoring essential. With its unique mechanism of action, Esentra 120 mg Injection not only addresses immediate health concerns but also contributes to a better quality of life for individuals battling advanced malignancies. Always consult your healthcare provider to ensure Esentra is the right choice for your treatment plan.
數量
Active Pharmaceutical Ingredient
Uses
• Esentra 120 mg injection is primarily used for the treatment of osteoporosis in postmenopausal women. This medication helps to increase bone density and reduce the risk of fractures. By inhibiting bone resorption, Esentra 120 mg injection contributes to maintaining stronger bones. It is often prescribed to patients who are at high risk for osteoporosis-related complications.
• In addition to treating osteoporosis, Esentra 120 mg injection is utilized in patients with bone loss due to cancer treatments. It assists in managing the side effects that can arise from certain cancer therapies, helping to preserve bone strength. This is particularly important for patients who may experience increased susceptibility to fractures. Esentra 120 mg injection plays a crucial role in the comprehensive care of these individuals.
• Esentra 120 mg injection is also indicated for patients with skeletal-related events due to bone metastases. It aids in reducing complications that can arise from tumors affecting bone integrity. By administering Esentra 120 mg injection, healthcare providers can help improve patients' quality of life. This use underscores the importance of managing bone health in oncology settings.
• Furthermore, Esentra 120 mg injection is beneficial for individuals with conditions that lead to excessive bone resorption, such as osteoporosis or metastatic bone disease. Its action helps to restore balance in bone remodeling, thus enhancing overall bone health. Healthcare providers often recommend Esentra 120 mg injection as part of a broader treatment strategy. This medication is essential in addressing the needs of patients facing bone health challenges.
Benefits
Esentra 120 mg Injection binds to RANKL, a protein that is essential for the formation, function, and survival of osteoclasts (the cells responsible for bone resorption). It inhibits osteoclast formation, function, and survival, thereby decreasing bone resorption and increasing bone mass and strength of the bone. Along with this treatment, your doctor might ask you to make certain lifestyle changes, such as maintaining good oral hygiene and quitting smoking. Your doctor may ask you to undergo a dental examination before you start the treatment.
Side Effects
Esentra 120 mg Injection has many adverse effects if it is used in the wrong way. But it varies from person to person, and if you want, you can consult your doctor regarding these adverse effects.
Most Common Side Effects
• Arm or leg pain
• Joint pain
• Muscle or bone pain
• Constipation,
• Abdominal discomfort
• Hair loss
• Skin rash
• Tingling, pain, or numbness that moves down your leg
Common Side Effects
• Upper respiratory tract infection
• Frequent or painful urination, blood in urine, inability to hold urine
• Musculoskeletal
• Severe leg or joint pain
How To Use
Esentra 120 mg Injection can be administered to you subcutaneously (under the skin) by a doctor or nurse. You should also take calcium and vitamin D supplements while being on treatment with Esentra Denosumab 120 mg Injection. Your doctor will determine the correct dose and duration for you, taking into account your age, body weight, and disease condition.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Osteoporosis Esentra 120 mg Injection. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Esentra 120 should be used with caution in patients having severe kidney problems. Patients with severe kidney impairment (creatinine clearance < 30 mL/min) or receiving dialysis are at greater risk of developing hypocalcemia. Consult your doctor before receiving Esentra Denosumab 120 mg Injection.
• Breastfeeding: Esentra 120 mg Injection is excreted in milk is unknown. So it is better to consult a healthcare provider if you are a breastfeeding mother before taking this medication.
• Liver: Esentra 120 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Osteoporosis Esentra 120 mg Injection and report any unusual symptoms or changes in liver function to their doctor. The dose of Osteoporosis Esentra 120 mg Injection may need to be adjusted in patients with liver disease.
• Pregnancy: Esentra 120 mg Injection is not recommended for use in pregnant women and women of childbearing potential not using contraception. Women should be advised not to become pregnant during and for at least 5 months after treatment with Denosumab Esentra 120 mg. Seek your doctor's advice, as studies on pregnant women and animals have shown significant harmful effects on the developing baby.
• Driving: Esentra 120 mg Injection has no or negligible influence on the ability to drive and use machines.